Share Price and Basic Stock Data
Last Updated: January 9, 2026, 5:29 pm
| PEG Ratio | -5.48 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
BASF India Ltd operates in the chemicals sector, specifically focusing on organic chemicals. The company’s stock price stood at ₹3,819, with a market capitalization of ₹16,536 Cr. Recent quarterly sales showed a positive trajectory, with revenues rising from ₹3,582 Cr in September 2022 to ₹3,707 Cr in September 2023. This upward trend continued with a projected sale of ₹4,248 Cr by September 2024. The trailing twelve months (TTM) sales reported was ₹14,604 Cr, demonstrating a growth from ₹13,100 Cr in FY 2022 to ₹13,645 Cr in FY 2023. Despite fluctuations in quarterly performance, the overall revenue growth indicates a robust demand for its products, aligning with the global chemical industry’s recovery post-pandemic. The company’s operational efficiency is reflected in its operating profit margin (OPM) of 4%, which, while lower than sector norms, still showcases a focus on maintaining profitability amidst rising costs.
Profitability and Efficiency Metrics
BASF India reported a net profit of ₹399 Cr for the latest financial year, with a net profit margin of 3.29%. The company’s operating profit for FY 2025 is projected at ₹747 Cr, indicating some challenges compared to the previous year’s ₹687 Cr. The operating profit margin (OPM) has been relatively stable, recorded at 5% in FY 2023, with a slight improvement to 6% in FY 2024. The return on equity (ROE) was reported at 13.7%, while return on capital employed (ROCE) was at 18.0%, indicating effective capital utilization. The interest coverage ratio (ICR) stood at 53.17x, showcasing strong earnings relative to interest expenses, which is significantly higher than typical sector benchmarks. However, the company faces risks from rising operational costs, which could impact margins if not managed effectively. Overall, while profitability metrics reflect a solid performance, ongoing cost pressures require vigilant management.
Balance Sheet Strength and Financial Ratios
BASF India’s balance sheet demonstrates significant resilience, with total assets reported at ₹8,330 Cr and total liabilities at ₹8,330 Cr, indicating a balanced structure. The company reported reserves of ₹3,771 Cr, up from ₹2,658 Cr in FY 2023, which enhances its financial flexibility. Borrowings stood at ₹144 Cr, showcasing prudent debt management with a low debt-to-equity ratio. The price-to-book value (P/BV) ratio was recorded at 5.25x, suggesting that the stock is trading at a premium compared to its book value, which stood at ₹844.79 per share. The current ratio of 1.55x indicates a strong liquidity position, ensuring the company can meet its short-term obligations comfortably. However, the inventory turnover ratio of 6.18x is considerably higher than previous years, suggesting improved inventory management but also highlighting the need for continuous monitoring of stock levels to prevent overstocking.
Shareholding Pattern and Investor Confidence
The shareholding pattern of BASF India reflects a stable and confident investor base, with promoters holding 73.33% of the equity. Domestic institutional investors (DIIs) accounted for 6.43%, while foreign institutional investors (FIIs) held 4.14%. The public shareholding stood at 16.09%, which shows a healthy distribution of shares. Notably, the number of shareholders increased from 52,119 in September 2023 to 63,572 in September 2025, indicating growing investor interest. This stability in shareholding is crucial for maintaining investor confidence, especially in a volatile market environment. The consistent promoter holding suggests a long-term commitment to the company’s growth strategy. However, the gradual decline in public shareholding percentage may raise concerns about liquidity in the stock, which could affect trading dynamics in the future.
Outlook, Risks, and Final Insight
Looking ahead, BASF India is well-positioned to capitalize on the increasing demand for organic chemicals, especially as the global economy continues to recover. The company’s focus on operational efficiency and cost management will be vital in maintaining profitability amidst rising input costs. However, potential risks include fluctuations in raw material prices and global economic uncertainties, which could impact revenue stability. Additionally, regulatory changes in the chemicals sector may pose challenges. Should BASF India effectively navigate these risks, it can enhance its market share and profitability. Conversely, failure to manage costs or adapt to market changes could hinder growth. Overall, BASF India presents a mix of opportunities and challenges, making it a compelling watch for investors looking for exposure in the chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 83.5 Cr. | 234 | 456/202 | 194 | 392 | 0.04 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,394 Cr. | 9,327 | 14,250/8,150 | 53.5 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 32.7 Cr. | 109 | 329/106 | 16.2 | 26.9 | 0.92 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 245 Cr. | 307 | 435/163 | 13.6 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,574.17 Cr | 1,498.82 | 61.96 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,582 | 2,898 | 3,277 | 3,375 | 3,707 | 3,326 | 3,360 | 3,967 | 4,248 | 3,759 | 3,189 | 3,752 | 3,904 |
| Expenses | 3,394 | 2,843 | 3,143 | 3,177 | 3,473 | 3,114 | 3,114 | 3,654 | 4,047 | 3,588 | 3,126 | 3,530 | 3,750 |
| Operating Profit | 188 | 55 | 134 | 198 | 234 | 212 | 246 | 312 | 201 | 170 | 63 | 222 | 154 |
| OPM % | 5% | 2% | 4% | 6% | 6% | 6% | 7% | 8% | 5% | 5% | 2% | 6% | 4% |
| Other Income | 10 | 12 | 27 | 9 | 16 | 27 | 25 | 36 | 18 | 19 | 43 | 21 | 27 |
| Interest | 4 | 3 | 2 | 8 | 2 | 3 | 3 | 5 | 3 | 4 | 4 | 5 | 8 |
| Depreciation | 45 | 46 | 47 | 47 | 47 | 49 | 48 | 47 | 45 | 48 | 38 | 38 | 37 |
| Profit before tax | 149 | 18 | 112 | 152 | 200 | 187 | 219 | 297 | 171 | 138 | 64 | 201 | 136 |
| Tax % | 24% | 41% | 27% | 26% | 26% | 25% | 26% | 26% | 25% | 25% | 27% | 27% | 25% |
| Net Profit | 113 | 11 | 82 | 113 | 149 | 140 | 162 | 221 | 128 | 104 | 47 | 147 | 101 |
| EPS in Rs | 26.13 | 2.46 | 19.03 | 26.03 | 34.45 | 32.36 | 37.31 | 50.96 | 29.56 | 23.93 | 10.88 | 34.00 | 23.34 |
Last Updated: January 2, 2026, 7:31 am
Below is a detailed analysis of the quarterly data for BASF India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 3,904.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,752.00 Cr. (Jun 2025) to 3,904.00 Cr., marking an increase of 152.00 Cr..
- For Expenses, as of Sep 2025, the value is 3,750.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,530.00 Cr. (Jun 2025) to 3,750.00 Cr., marking an increase of 220.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 154.00 Cr.. The value appears to be declining and may need further review. It has decreased from 222.00 Cr. (Jun 2025) to 154.00 Cr., marking a decrease of 68.00 Cr..
- For OPM %, as of Sep 2025, the value is 4.00%. The value appears to be declining and may need further review. It has decreased from 6.00% (Jun 2025) to 4.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Jun 2025) to 27.00 Cr., marking an increase of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Jun 2025) to 8.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 37.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 38.00 Cr. (Jun 2025) to 37.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 136.00 Cr.. The value appears to be declining and may need further review. It has decreased from 201.00 Cr. (Jun 2025) to 136.00 Cr., marking a decrease of 65.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Jun 2025) to 25.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 101.00 Cr.. The value appears to be declining and may need further review. It has decreased from 147.00 Cr. (Jun 2025) to 101.00 Cr., marking a decrease of 46.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 23.34. The value appears to be declining and may need further review. It has decreased from 34.00 (Jun 2025) to 23.34, marking a decrease of 10.66.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,430 | 4,706 | 4,749 | 5,073 | 5,583 | 6,026 | 7,595 | 9,558 | 13,100 | 13,645 | 13,767 | 15,162 | 14,604 |
| Expenses | 4,146 | 4,572 | 4,642 | 4,802 | 5,238 | 5,861 | 7,316 | 8,926 | 12,188 | 12,958 | 12,878 | 14,415 | 13,994 |
| Operating Profit | 284 | 133 | 107 | 271 | 346 | 165 | 279 | 633 | 911 | 687 | 890 | 747 | 609 |
| OPM % | 6% | 3% | 2% | 5% | 6% | 3% | 4% | 7% | 7% | 5% | 6% | 5% | 4% |
| Other Income | -3 | 39 | 173 | 27 | 182 | 139 | -4 | 419 | 37 | 53 | 76 | 116 | 110 |
| Interest | 16 | 96 | 148 | 142 | 113 | 85 | 83 | 38 | 17 | 14 | 16 | 16 | 20 |
| Depreciation | 71 | 142 | 163 | 169 | 153 | 147 | 181 | 174 | 171 | 182 | 191 | 178 | 160 |
| Profit before tax | 194 | -66 | -30 | -12 | 261 | 72 | 10 | 840 | 760 | 543 | 759 | 670 | 538 |
| Tax % | 34% | 2% | 0% | 13% | 6% | -14% | -131% | 34% | 22% | 26% | 26% | 25% | |
| Net Profit | 128 | -67 | -30 | -14 | 246 | 82 | 23 | 553 | 595 | 403 | 563 | 499 | 399 |
| EPS in Rs | 29.54 | -15.46 | -7.02 | -3.26 | 56.95 | 18.88 | 5.28 | 127.67 | 137.42 | 93.08 | 130.15 | 115.33 | 92.15 |
| Dividend Payout % | 14% | -26% | -14% | -31% | 5% | 26% | 57% | 8% | 4% | 9% | 12% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -152.34% | 55.22% | 53.33% | 1857.14% | -66.67% | -71.95% | 2304.35% | 7.59% | -32.27% | 39.70% | -11.37% |
| Change in YoY Net Profit Growth (%) | 0.00% | 207.57% | -1.89% | 1803.81% | -1923.81% | -5.28% | 2376.30% | -2296.75% | -39.86% | 71.97% | -51.07% |
BASF India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 58% |
| 3 Years: | -7% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 26% |
| 3 Years: | 13% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:40 am
Balance Sheet
Last Updated: December 10, 2025, 2:27 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 |
| Reserves | 1,207 | 1,119 | 1,073 | 1,059 | 1,301 | 1,370 | 1,201 | 1,743 | 2,293 | 2,658 | 3,180 | 3,614 | 3,771 |
| Borrowings | 1,067 | 1,600 | 1,349 | 1,275 | 868 | 912 | 822 | 286 | 122 | 106 | 156 | 157 | 144 |
| Other Liabilities | 1,717 | 1,406 | 1,311 | 1,498 | 1,635 | 1,524 | 2,764 | 3,072 | 3,652 | 3,758 | 3,853 | 4,517 | 3,542 |
| Total Liabilities | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 | 7,500 |
| Fixed Assets | 526 | 1,351 | 1,289 | 1,222 | 1,117 | 957 | 965 | 817 | 763 | 793 | 759 | 694 | 682 |
| CWIP | 792 | 74 | 55 | 33 | 27 | 42 | 23 | 53 | 100 | 19 | 61 | 84 | 120 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 213 | 213 |
| Other Assets | 2,716 | 2,743 | 2,433 | 2,619 | 2,702 | 2,850 | 3,842 | 4,274 | 5,247 | 5,753 | 6,413 | 7,339 | 6,485 |
| Total Assets | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 | 7,500 |
Below is a detailed analysis of the balance sheet data for BASF India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 43.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 43.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,771.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,614.00 Cr. (Mar 2025) to 3,771.00 Cr., marking an increase of 157.00 Cr..
- For Borrowings, as of Sep 2025, the value is 144.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 157.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,542.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,517.00 Cr. (Mar 2025) to 3,542.00 Cr., marking a decrease of 975.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,500.00 Cr.. The value appears to be improving (decreasing). It has decreased from 8,330.00 Cr. (Mar 2025) to 7,500.00 Cr., marking a decrease of 830.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 682.00 Cr.. The value appears to be declining and may need further review. It has decreased from 694.00 Cr. (Mar 2025) to 682.00 Cr., marking a decrease of 12.00 Cr..
- For CWIP, as of Sep 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 36.00 Cr..
- For Investments, as of Sep 2025, the value is 213.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 213.00 Cr..
- For Other Assets, as of Sep 2025, the value is 6,485.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,339.00 Cr. (Mar 2025) to 6,485.00 Cr., marking a decrease of 854.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8,330.00 Cr. (Mar 2025) to 7,500.00 Cr., marking a decrease of 830.00 Cr..
Notably, the Reserves (3,771.00 Cr.) exceed the Borrowings (144.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 283.00 | 132.00 | 106.00 | 270.00 | -522.00 | -747.00 | -543.00 | 347.00 | 789.00 | 581.00 | 734.00 | 590.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 72 | 80 | 77 | 71 | 63 | 68 | 79 | 73 | 63 | 67 | 60 |
| Inventory Days | 136 | 106 | 85 | 93 | 94 | 99 | 93 | 73 | 66 | 71 | 68 | 80 |
| Days Payable | 138 | 98 | 117 | 120 | 117 | 103 | 133 | 126 | 112 | 108 | 114 | 118 |
| Cash Conversion Cycle | 69 | 80 | 49 | 50 | 48 | 59 | 28 | 25 | 26 | 26 | 21 | 23 |
| Working Capital Days | 49 | 43 | 43 | 36 | 28 | 32 | 10 | 26 | 34 | 37 | 44 | 40 |
| ROCE % | 12% | 0% | -2% | 5% | 9% | 1% | 6% | 23% | 34% | 20% | 25% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Small Cap Fund | 763,051 | 2.78 | 317.19 | 763,051 | 2025-04-22 17:25:40 | 0% |
| Tata Large & Mid Cap Fund | 263,657 | 1.25 | 109.6 | N/A | N/A | N/A |
| Quant Small Cap Fund | 243,197 | 0.34 | 101.09 | 170,585 | 2025-12-15 01:00:05 | 42.57% |
| ICICI Prudential Smallcap Fund | 23,493 | 0.12 | 9.77 | 112,260 | 2025-12-07 01:05:46 | -79.07% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Diluted EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Cash EPS (Rs.) | 156.38 | 174.30 | 135.13 | 176.81 | 167.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Dividend / Share (Rs.) | 20.00 | 15.00 | 8.00 | 6.00 | 10.00 |
| Revenue From Operations / Share (Rs.) | 3502.51 | 3180.29 | 3151.95 | 3026.04 | 2207.98 |
| PBDIT / Share (Rs.) | 190.97 | 223.07 | 167.26 | 216.08 | 150.00 |
| PBIT / Share (Rs.) | 149.91 | 178.91 | 125.20 | 176.68 | 109.83 |
| PBT / Share (Rs.) | 154.75 | 175.32 | 125.53 | 175.54 | 194.03 |
| Net Profit / Share (Rs.) | 115.32 | 130.13 | 93.07 | 137.41 | 127.65 |
| PBDIT Margin (%) | 5.45 | 7.01 | 5.30 | 7.14 | 6.79 |
| PBIT Margin (%) | 4.27 | 5.62 | 3.97 | 5.83 | 4.97 |
| PBT Margin (%) | 4.41 | 5.51 | 3.98 | 5.80 | 8.78 |
| Net Profit Margin (%) | 3.29 | 4.09 | 2.95 | 4.54 | 5.78 |
| Return on Networth / Equity (%) | 13.65 | 17.47 | 14.91 | 25.46 | 30.93 |
| Return on Capital Employeed (%) | 16.85 | 22.73 | 18.99 | 30.89 | 24.40 |
| Return On Assets (%) | 5.99 | 7.78 | 6.13 | 9.73 | 10.74 |
| Asset Turnover Ratio (%) | 1.95 | 2.00 | 2.15 | 2.33 | 1.96 |
| Current Ratio (X) | 1.55 | 1.59 | 1.47 | 1.37 | 1.27 |
| Quick Ratio (X) | 0.92 | 1.04 | 0.87 | 0.83 | 0.78 |
| Inventory Turnover Ratio (X) | 6.18 | 2.09 | 2.27 | 2.23 | 1.81 |
| Dividend Payout Ratio (NP) (%) | 13.00 | 6.14 | 6.44 | 7.27 | 2.35 |
| Dividend Payout Ratio (CP) (%) | 9.59 | 4.58 | 4.43 | 5.65 | 1.78 |
| Earning Retention Ratio (%) | 87.00 | 93.86 | 93.56 | 92.73 | 97.65 |
| Cash Earning Retention Ratio (%) | 90.41 | 95.42 | 95.57 | 94.35 | 98.22 |
| Interest Coverage Ratio (X) | 53.17 | 62.18 | 52.05 | 53.54 | 17.28 |
| Interest Coverage Ratio (Post Tax) (X) | 30.75 | 37.27 | 28.86 | 34.33 | 5.01 |
| Enterprise Value (Cr.) | 18377.30 | 13821.16 | 9498.38 | 13225.93 | 8803.28 |
| EV / Net Operating Revenue (X) | 1.21 | 1.00 | 0.69 | 1.01 | 0.92 |
| EV / EBITDA (X) | 22.23 | 14.31 | 13.12 | 14.14 | 13.56 |
| MarketCap / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| Retention Ratios (%) | 86.99 | 93.85 | 93.55 | 92.72 | 97.64 |
| Price / BV (X) | 5.25 | 4.48 | 3.65 | 5.72 | 5.03 |
| Price / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| EarningsYield | 0.02 | 0.03 | 0.04 | 0.04 | 0.06 |
After reviewing the key financial ratios for BASF India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Diluted EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 156.38. This value is within the healthy range. It has decreased from 174.30 (Mar 24) to 156.38, marking a decrease of 17.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Dividend / Share (Rs.), as of Mar 25, the value is 20.00. This value exceeds the healthy maximum of 3. It has increased from 15.00 (Mar 24) to 20.00, marking an increase of 5.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3,502.51. It has increased from 3,180.29 (Mar 24) to 3,502.51, marking an increase of 322.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 190.97. This value is within the healthy range. It has decreased from 223.07 (Mar 24) to 190.97, marking a decrease of 32.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 149.91. This value is within the healthy range. It has decreased from 178.91 (Mar 24) to 149.91, marking a decrease of 29.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 154.75. This value is within the healthy range. It has decreased from 175.32 (Mar 24) to 154.75, marking a decrease of 20.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 115.32. This value is within the healthy range. It has decreased from 130.13 (Mar 24) to 115.32, marking a decrease of 14.81.
- For PBDIT Margin (%), as of Mar 25, the value is 5.45. This value is below the healthy minimum of 10. It has decreased from 7.01 (Mar 24) to 5.45, marking a decrease of 1.56.
- For PBIT Margin (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has decreased from 5.62 (Mar 24) to 4.27, marking a decrease of 1.35.
- For PBT Margin (%), as of Mar 25, the value is 4.41. This value is below the healthy minimum of 10. It has decreased from 5.51 (Mar 24) to 4.41, marking a decrease of 1.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 5. It has decreased from 4.09 (Mar 24) to 3.29, marking a decrease of 0.80.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.65. This value is below the healthy minimum of 15. It has decreased from 17.47 (Mar 24) to 13.65, marking a decrease of 3.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.85. This value is within the healthy range. It has decreased from 22.73 (Mar 24) to 16.85, marking a decrease of 5.88.
- For Return On Assets (%), as of Mar 25, the value is 5.99. This value is within the healthy range. It has decreased from 7.78 (Mar 24) to 5.99, marking a decrease of 1.79.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.95. It has decreased from 2.00 (Mar 24) to 1.95, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 1.55, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.92, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 6.18, marking an increase of 4.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 20. It has increased from 6.14 (Mar 24) to 13.00, marking an increase of 6.86.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 20. It has increased from 4.58 (Mar 24) to 9.59, marking an increase of 5.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 87.00. This value exceeds the healthy maximum of 70. It has decreased from 93.86 (Mar 24) to 87.00, marking a decrease of 6.86.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 90.41. This value exceeds the healthy maximum of 70. It has decreased from 95.42 (Mar 24) to 90.41, marking a decrease of 5.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.17. This value is within the healthy range. It has decreased from 62.18 (Mar 24) to 53.17, marking a decrease of 9.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 30.75. This value is within the healthy range. It has decreased from 37.27 (Mar 24) to 30.75, marking a decrease of 6.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 18,377.30. It has increased from 13,821.16 (Mar 24) to 18,377.30, marking an increase of 4,556.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 1.21, marking an increase of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 22.23. This value exceeds the healthy maximum of 15. It has increased from 14.31 (Mar 24) to 22.23, marking an increase of 7.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For Retention Ratios (%), as of Mar 25, the value is 86.99. This value exceeds the healthy maximum of 70. It has decreased from 93.85 (Mar 24) to 86.99, marking a decrease of 6.86.
- For Price / BV (X), as of Mar 25, the value is 5.25. This value exceeds the healthy maximum of 3. It has increased from 4.48 (Mar 24) to 5.25, marking an increase of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BASF India Ltd:
- Net Profit Margin: 3.29%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.85% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.65% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 30.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.92
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 42.1 (Industry average Stock P/E: 61.96)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.29%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Unit Nos. 10A, 10B, 10C (Part), 10th Floor, Godrej One, Pirojshanagar, Mumbai Maharashtra 400079 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradip P Shah | Chairman |
| Mr. Alexander Gerding | Managing Director |
| Mr. Anil Choudhary | Whole Time Director |
| Dr. Ramkumar Dhruva | Director |
| Mrs. Shyamala Gopinath | Director |
| Mr. Marcelo Rocha Lu | Director |
| Mr. Bahram Vakil | Director |
| Ms. Sonia Singh | Director |
| Mr. Narendranath J Baliga | Whole Time Director |
| Mr. Manohar Kamath | Director - Legal |
FAQ
What is the intrinsic value of BASF India Ltd?
BASF India Ltd's intrinsic value (as of 09 January 2026) is ₹4086.62 which is 9.27% higher the current market price of ₹3,740.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹16,196 Cr. market cap, FY2025-2026 high/low of ₹5,424/3,736, reserves of ₹3,771 Cr, and liabilities of ₹7,500 Cr.
What is the Market Cap of BASF India Ltd?
The Market Cap of BASF India Ltd is 16,196 Cr..
What is the current Stock Price of BASF India Ltd as on 09 January 2026?
The current stock price of BASF India Ltd as on 09 January 2026 is ₹3,740.
What is the High / Low of BASF India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BASF India Ltd stocks is ₹5,424/3,736.
What is the Stock P/E of BASF India Ltd?
The Stock P/E of BASF India Ltd is 42.1.
What is the Book Value of BASF India Ltd?
The Book Value of BASF India Ltd is 881.
What is the Dividend Yield of BASF India Ltd?
The Dividend Yield of BASF India Ltd is 0.53 %.
What is the ROCE of BASF India Ltd?
The ROCE of BASF India Ltd is 18.0 %.
What is the ROE of BASF India Ltd?
The ROE of BASF India Ltd is 13.7 %.
What is the Face Value of BASF India Ltd?
The Face Value of BASF India Ltd is 10.0.